Late relapse of embryonal rhabdomyosarcoma, botryoid variant, of the vagina

Pediatric Blood and Cancer

Volumn 51, Issue 1, 2008, Pages 140-141

  Vasquez, Roberto ^a   Collini, Paola ^a   Meazza, Cristina ^a   Favini, Francesca ^a   Casanova, Michela ^a   Ferrari, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chemotherapy; Hormone receptors; Menarche; Rhabdomyosarcoma

Indexed keywords

ESTROGEN RECEPTOR; ESTRONE;

ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CASE REPORT; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENARCHE; PRESCHOOL CHILD; PRIORITY JOURNAL; VAGINA BLEEDING; VAGINA CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; RECEPTORS, ESTROGEN; RECURRENCE; RHABDOMYOSARCOMA, EMBRYONAL; TREATMENT OUTCOME; VAGINAL NEOPLASMS;

EID: 44149118414     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21482     Document Type: Article

References (9)

1. Wexler LH, Meyer WH, Helman LJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 5th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp. 971-1001.
2. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 1999; 17:3487-3493.
3. Sung L, Anderson JR, Donaldson SS, et al. Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Eur J Cancer 2004;40:1878-1885.
4. Mazzoleni S, Bisogno G, Garaventa A, et al. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer 2005;104:183-190.
5. Leuschner I, Harms D, Mattke A, et al. Rhabdomyosarcoma of the urinary bladder and vagina. A clinicopathologic study with emphasis on recurrent disease: A report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 2001;25: 856-864.
6. Diller L, Sexsmith E, Gottlieb A, et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 1995;95:1606-1611.
7. Gripp KW, Scott CI, Jr., Nicholson L, et al. Five additional Costello syndrome patients with rhabdomyosarcoma: Proposal for a tumor screening protocol. Am J Med Genet 2002;108:80-87.
8. Ferrari A, Bisogno G, Macaluso A, et al. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer 2007;109:1406-1412.
9. Zacharin M, Waters K, Chow CW, et al. Recurrent rhabdomyosarcoma after 25 years: A possible association with estrogens and progestogen therapy. J Pediatr Haematol Oncol 1997;19:477-481.